Sign in

Trial result ·

Collaborative Care for Opioid Use Disorder and Mental Illness: The CLARO Randomized Clinical Trial.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This trial tested team-based care for opioid use disorder with depression or PTSD. 797 adults were randomized in 18 primary care clinics. The clinics were in California and New Mexico. The team care ran for 6 months. It used a care manager, an addiction psychiatrist and a primary care clinician. The other group got enhanced usual care.

What they found

The main results showed no clear difference between groups. These were time to the first buprenorphine fill and days of buprenorphine. They also included depression scores and PTSD scores. Secondary results also showed no difference. Both groups improved from the start. Exploratory analyses of people who got the care hinted at gains in OUD outcomes.

What it means for patients

The authors say team care showed no proof of greater gains than enhanced usual care. They give possible reasons. These include spillover and spontaneous improvement. Another reason is how well the care fits complex cases. Settings with few mental health workers may matter too.

Why it is not certain yet

Not everyone completed the 6-month survey. The analyses of people who got the care were exploratory. They show hints only.

The registered trials

The paper names these trials from a public trial registry. Each trial page shows who the trial is for, its sites and its status.

Source

Collaborative Care for Opioid Use Disorder and Mental Illness: The CLARO Randomized Clinical Trial.

PubMed · PMID 41460640

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Depression publications
Collaborative Care for Opioid Use Disorder and Mental Illness: The CLARO Randomized Clinical Trial. · Depression news explained – Frontlight Research